Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on NorthStar Medical Technologies — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

NorthStar Medical Radioisotopes and BWXT Medical Sign Master Services Agreement to Support Actinium-225 Production

Jul 22, 2024•almost 2 years ago

Contract Type

agreement

BeloitBiotechnologyHealth CareMedicalMedical Device

Description

NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd. have signed a Master Services Agreement (MSA) to facilitate the production of actinium-225 (Ac-225), a critical medical isotope used in cancer treatments. The agreement also includes potential target design projects and exploration of opportunities to provide backup supply to each other’s customers.

Company Information

Company

NorthStar Medical Technologies

Location

Beloit, Wisconsin, United States

About

NorthStar Medical Technologies, LLC, parent company of NorthStar Medical Radioisotopes, LLC, is a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases.

Predictive Intelligence
Strategic

ML-powered predictions for NorthStar Medical Technologies's next move

Learn about Strategic plan

Related People

Suggested for you

Sign in to view contact details

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months